CLINICAL EVALUATION OF AC-1370 IN THE PULMONARY INFECTIONS

CLINICAL EVALUATION OF AC-1370 IN THE PULMONARY INFECTIONS

AC-1370 a new cephalosporin with strong antimicrobial activity against a broad spectrum of Gramnegative bacteria, especially P. aeruginosa was administered intravenously 1-2 g 2 times a day to 8 patients with pulmonary infections to evaluate therapeutic efficacy. The results obtained as follow: 1) E...

Full description

Saved in:
Bibliographic Details
Published in:CHEMOTHERAPY Vol. 32; no. Supplement9; pp. 395 - 398
Main Authors: ONARI, KIYOSHI, TSUYA, TAKASHI, HAYASHI, HIROSHI, ISHIOKA, SHINICHI, MATSUZAKA, SHIGERU, NISHIMOTO, YUKIO
Format: Journal Article
Language:English
Japanese
Published: Japanese Society of Chemotherapy 1984
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AC-1370 a new cephalosporin with strong antimicrobial activity against a broad spectrum of Gramnegative bacteria, especially P. aeruginosa was administered intravenously 1-2 g 2 times a day to 8 patients with pulmonary infections to evaluate therapeutic efficacy. The results obtained as follow: 1) Excellent and good clinical responses were obtained in 6 to 8 patients (75%). 2) No marked side effects were observed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.32.Supplement9_395